hsa-miR-210, which was up-regulated in HCC, significantly down-regulated 7 target genes (JDP2, SAA1, CR1, SHMT1, KMO, NOL4, and EHD3) in HCC tissues. The gene discussed is CR1; the disease is hepatocellular carcinoma.